Alpha Cognition Receives Notice of Allowance for Composition-of-Matter Patent for ZUNVEYL for Mild to Moderate Alzheimer's Disease

BusinesswireAug 19 20:30

Alpha Cognition to Temporarily Delay Its Planned Uplisting to the Nasdaq

Seeking AlphaAug 14 05:30

Alpha Cognition, Inc. On Track to Secure Financing for Continued Growth

BusinesswireAug 14 05:02

Alpha Cognition Reports Q2 Results

Seeking AlphaAug 14 01:34

ALPHA COGNITION INC | 10-Q: Q2 2024 Earnings Report

SECAug 13 04:13 · Announcements

Alpha Cognition Stock Jumps on Alzheimer's Drug Approval

Seeking AlphaJul 29 22:32